Skip to main content

Table 1 Microbiological spectrum and antimicrobial susceptibilities in patients with endophthalmitis following open globe injuries

From: Endophthalmitis after open globe injuries: changes in microbiological spectrum and isolate susceptibility patterns over 14 years

Organism

Total/percentage(previous study)2

Total/percentage (current study)

Amikacin

Cefazolin

Ceftazidime

Chloramphenicol

Gentamicin

Gatifloxacin

Ciprofloxacin

Moxifloxacin

Vancomycin

Ofloxacin

   

n

S

%

n

S

%

n

S

%

n

S

%

n

S

%

n

S

%

n

S

%

n

S

%

n

S

%

n

S

%

Gram-positive cocci

63/45.3

296/47.7

274

155

56.5

294

266

90.4

137

79

57.6

295

284

96.2

295

217

73.5

292

263

90.1

296

219

73.9

239

206

86.2

289

284

98.2

295

240

81.4

 Coagulase-negative Staphylococcus

25/18

97/15.6

86

81

94.2

96

90

93.7

41

18

43.9

96

93

96.9

97

89

91.7

97

96

98.9

97

75

77.3

75

69

92

95

93

97.9

97

76

78.4

Staphylococcus aureus

5/3.6

11/1.8

11

11

100

11

11

100

5

3

60

11

11

100

11

10

90.9

11

10

90.9

11

5

45.4

10

8

80

11

11

100

11

6

54.5

Streptococcus sp.

30/21.6

172/27.7

163

52

31.9

172

154

89.5

81

54

66.6

172

166

96.5

172

108

62.7

169

143

84.6

172

127

73.8

143

119

83.2

168

165

98.2

171

143

83.6

 Other gram-positive cocci

3/2.2

16/2.6

14

11

78.6

15

11

73.3

10

4

40.0

16

14

87.5

15

10

66.7

15

14

93.3

16

12

75.0

11

10

90.9

15

15

100

16

15

93.7

Gram-positive bacilli

24/17.3

117/18.8

114

109

95.6

115

63

54.7

75

12

16

117

109

93.1

117

112

95.7

117

116

99.1

116

108

93.1

101

99

98.0

114

109

95.6

117

116

99.1

Bacillus sp.

20/14.4

106/17.1

103

101

98.1

104

54

51.9

67

8

11.9

106

98

92.4

106

105

99.1

106

105

99.0

106

101

95.2

94

92

97.9

103

98

95.1

106

106

100

 Other GPB

4/2.9

11/1.8

11

8

72.7

11

9

81.8

8

4

50

11

11

100

11

7

63.6

11

11

100

10

7

70

7

7

100

11

11

100

11

10

90.9

Gram negative organism

25/18

142/25

140

117

83.5

16

7

43.7

136

105

77.2

141

125

88.6

142

125

88.0

141

131

92.9

142

123

86.6

116

96

82.7

16

4

25

142

127

89.4

Pseudomonas sp.

10/7.2

16/2.6

16

12

75

1

0

0

16

11

68.7

16

5

31.2

16

12

75

16

12

75.0

16

11

68.7

13

8

61.5

1

0

0

16

11

68.7

Enterobacter sp.

2/1.4

25/4.0

25

22

88

5

2

40

23

21

91.3

25

24

96

24

23

95.8

25

24

96

25

24

96

19

19

100

5

2

40

25

24

96

E. coli

4/2.9

14/2.3

14

12

85.7

-

-

-

14

12

85.7

14

13

92.8

14

13

92.8

14

11

78.6

14

11

78.6

12

7

58.3

-

-

-

14

10

71.4

Haemophilus sp.

-

14/2.3

14

7

50

-

-

-

13

5

38.5

14

14

100

14

11

78.6

14

14

100

14

12

85.7

13

11

84.6

-

-

-

14

14

100

 Other gram-negative organisms

9/6.5

73/11.8

71

64

90.1

10

5

50

70

56

80

72

69

95.8

74

66

89.2

72

70

97.2

73

65

89

59

51

86.4

10

2

20

73

68

93.2

Corynebacterium

5/3.6

10/1.6

5

4

80

10

9

90

3

0

0

10

9

90

10

9

90

10

9

90.0

10

7

70

8

6

75.0

10

10

100

10

9

90

 Total bacteria

119/85.6

565/91.1

533

385

72.2

435

345

79.3

351

196

55.8

563

527

93.6

564

463

82.0

560

519

92.7

564

457

81.1

464

407

87.7

429

407

94.8

564

492

87.2

 Total fungi

20/14.4

55/8.9

Not done

  Aspergillus

9/6.5

20/3.2

  Acremonium

1/0.7

1/0.32

  Bipolaris

1/0.7

2/0.32

  Cladosporium

1/0.7

2/0.32

  Candida

-

3/0.48

  Fusarium

2/1.4

1/0.16

  1. All isolates were not tested for susceptibility to all antibiotics leading to ‘n’ being less than the total isolates. GPB, gram-positive bacilli; n, number of isolates tested for antibiotic susceptibility; S, number of isolates sensitive to the antibiotic.